Sunshine Biopharma, Inc
Price
FilingsNewest: S-1, Registration of sharesOct 2 →InsidersNo open-market buys or sales.→HoldersJane Street 0.6%Morgan Stanley 0.0%SBI Securities 0.0%→Financing →PeersClosest companies: CPIX, EDSA, IONS→
From the filings
Figures
- Revenue
- $35.3Mlast 12 months
- Net income
- −$5.8Mlast 12 months
- Operating cash flow
- −$5.7Mlast 12 months
- Cash and equivalents
- $13.7Mat the last balance sheet
- Shares outstanding
- 2.4M shareson issue